Oncology Articles

Changing Paradigms in the Treatment of Renal Cancer
Ulka Vaishampayan
Oncology & Hematology Review. 2018;14(1):Epub ahead of print.
New advances in the treatment of non-small-cell lung cancer?
Suresh S Ramalingam
Oncology & Hematology Review. 2018;14(1):Epub ahead of print.
Detecting an ALK Rearrangement via Liquid Biopsy Enabled a Targeted Therapy-based Approach for Treating a Patient with Advanced Non-small Cell Lung Cancer
Alejandro R Calvo, Gabriel H Ibarra, Cecile Rose T Vibat, Veena M Singh
Oncology & Hematology Review. 2018;14(1): Epub ahead of print
Advances in Cancer Research and Translational Medicine
Elaine R Mardis
Oncology & Hematology Review. 2018;14(1):Epub ahead of print.
Radiopharmaceuticals for the Detection of Recurrent Prostate Cancer
Bertrand Tombal
European Oncology & Haematology. 2018;14(1):Epub ahead of print.
The Belarus Experience of Pelvic Artery Embolisation in Patients with Advanced and Recurrent Cervical Cancer Presenting with Haemorrhage
Olga P Matylevich, Vladimir V Akinfeev, Thomas C Randall, Kathleen M Schmeler, Oleg G Sukonko
European Oncology & Haematology, 2018;14(1):Epub ahead of print
Rolapitant in the Current Management of Chemotherapy-induced Nausea and Vomiting
Bernardo L Rapoport, Pere Gascon, Florian Scotte, Karin Jordan, Massimo Di Maio, Sussanne Borjeson, Sam H Ahmedzai
European Oncology & Haematology, 2018;14(1):[Online only]
More than a Gel – Hyaluronic Acid, a Central Component in the Microenvironment of Pancreatic Cancer
Thomas Seufferlein, Michel Ducreux, Manuel Hidalgo, Gerald Prager, Eric Van Cutsem
European Oncology & Haematology. 2018;14(1):Epub ahead of print.
The Impact of Biosimilars in Supportive Care in Cancer
Matti S Aapro, Paul Cornes
European Oncology & Haematology. 2018;14(1):Epub ahead of print.
Erratum to: Cytogenetic, Inflammatory, Immunologic, and Infectious Basis for Dysplastic Hematopoeisis
Pedro Alcedo, Enrique Andrade, Hussein Hamad, Gustavo Rivero
Oncology & Hematology Review, 2017;14(1):[online only]
Exercise for Toxicity Management in Cancer—A Narrative Review
Ian R Kleckner, Richard F Dunne, Matthew Asare, Calvin Cole, Fergal Fleming, Chunkit Fung, Po-Ju Lin, Karen M Mustian
Oncology & Hematology Review, 2018;14(1): Epub ahead of print.
Bmi1 – A Path to Targeting Cancer Stem Cells
David Bakhshinyan, Ashley A Adile, Chitra Venugopal, Sheila K Singh
European Oncology & Haematology, 2017;13(2):147–51 DOI: https://doi.org/10.17925/EOH.2017.13.02.147
Systemic Chemotherapy for Urothelial Cancer – How to Select Systemic Therapy in Bladder Cancer
Aristotelis Bamias, Ioannis Dimitriadis
European Oncology & Haematology, 2017;13(2):134–8 DOI: https://doi.org/10.17925/EOH.2017.13.02.134
Rolapitant in the Current Management of Chemotherapy-induced Nausea and Vomiting
Bernardo L Rapoport, Karin Jordan, Pere Gascon, Florian Scotte, Massimo Di Maio, Sussanne Borjeson, Sam H Ahmedzai
European Oncology & Haematology, 2017;13(2):120–6 DOI: https://doi.org/10.17925/EOH.2017.13.02.120
Potential Solutions for Sustaining the Costs of Cancer Drugs
Gilberto Lopes, Arnold Vulto, Nils Wilking, Wim van Harten, Klaus Meier, Steven Simoens
European Oncology & Haematology, 2017;13(2):102–7 DOI: https://doi.org/10.17925/EOH.2017.13.02.102
Call for Submissions 2018
Axel S Merseburger
European Oncology & Haematology, 2017;13(2):101 DOI: https://doi.org/10.17925/EOH.2017.13.02.101
The Changing Therapeutic Landscape in Metastatic Prostate Cancer
Alan J Koletsky
Oncology & Hematology Review, 2017;13(2):112–6 DOI: https://doi.org/10.17925/OHR.2017.13.02.112
Breaking the Barrier—PEGylated Recombinant Human Hyaluronidase (PEGPH20)—A New Therapeutic Approach to the Treatment of Pancreatic Ductal Adenocarcinoma
Andrew Hendifar, Andrea Bullock
Oncology & Hematology Review, 2017;13(2):107–11 DOI: https://doi.org/10.17925/OHR.2017.13.02.107
Metastatic Uveal Melanoma—A Review of Current Therapies and Future Directions
Emily N Kinsey, April KS Salama
Oncology & Hematology Review, 2017;13(2):100–6 DOI: https://doi.org/10.17925/OHR.2017.13.02.100
Updates in Adult Acute Lymphoblastic Leukemia—Current Status of Antigentargeted Treatments and Immunotherapy
Xavier Thomas
Oncology & Hematology Review, 2017;13(2):92–9 DOI: https://doi.org/10.17925/OHR.2017.13.02.92